- Home
- VRDN vs VRTS Comparison
VRDN vs VRTS Comparison
Compare VRDN & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- VRTS
- Stock Information
- Founded
- VRDN 2006
- VRTS 1988
- Country
- VRDN United States
- VRTS United States
- Employees
- VRDN N/A
- VRTS N/A
- Industry
- VRDN Medical Specialities
- VRTS Investment Managers
- Sector
- VRDN Health Care
- VRTS Finance
- Exchange
- VRDN Nasdaq
- VRTS Nasdaq
- Market Cap
- VRDN 1.5B
- VRTS 1.4B
- IPO Year
- VRDN N/A
- VRTS 1992
- Fundamental
- Price
- VRDN $18.72
- VRTS $194.28
- Analyst Decision
- VRDN Strong Buy
- VRTS Hold
- Analyst Count
- VRDN 11
- VRTS 4
- Target Price
- VRDN $38.80
- VRTS $188.25
- AVG Volume (30 Days)
- VRDN 894.1K
- VRTS 82.2K
- Earning Date
- VRDN 08-06-2025
- VRTS 10-24-2025
- Dividend Yield
- VRDN N/A
- VRTS 4.64%
- EPS Growth
- VRDN N/A
- VRTS 37.35
- EPS
- VRDN N/A
- VRTS 20.53
- Revenue
- VRDN $305,000.00
- VRTS $888,980,000.00
- Revenue This Year
- VRDN N/A
- VRTS N/A
- Revenue Next Year
- VRDN $35,092.81
- VRTS $1.36
- P/E Ratio
- VRDN N/A
- VRTS $9.45
- Revenue Growth
- VRDN 5.90
- VRTS 0.99
- 52 Week Low
- VRDN $9.90
- VRTS $142.18
- 52 Week High
- VRDN $27.20
- VRTS $252.82
- Technical
- Relative Strength Index (RSI)
- VRDN 55.80
- VRTS 47.86
- Support Level
- VRDN $18.12
- VRTS $190.93
- Resistance Level
- VRDN $20.05
- VRTS $200.00
- Average True Range (ATR)
- VRDN 1.02
- VRTS 5.16
- MACD
- VRDN -0.02
- VRTS -0.22
- Stochastic Oscillator
- VRDN 55.81
- VRTS 38.62
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About VRTS Virtus Investment Partners Inc.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.